DEVAL LASHKARI

Deval Lashkari stands as a distinguished Partner at Telegraph Hill Partners (THP), a premier venture capital firm renowned for its deep expertise and strategic investments across the healthcare and life sciences landscape. As a key member of the THP team, Deval plays a pivotal role in identifying, evaluating, and nurturing groundbreaking companies that are poised to redefine patient care and accelerate scientific discovery. His contributions are instrumental in solidifying Telegraph Hill Partners' reputation as a leader in healthcare innovation funding.

Deval Lashkari's investment focus is sharply honed on several critical areas within healthcare and life sciences. He is particularly active in the diagnostics sector, supporting companies that develop advanced tools and platforms for more accurate and earlier disease detection. His portfolio also extends to research tools, where he backs firms creating cutting-edge technologies that empower scientists to push the boundaries of biological understanding. Furthermore, Deval has a keen interest in digital health, recognizing its transformative potential to improve healthcare delivery, patient engagement, and operational efficiency through technology-driven solutions. This targeted approach ensures that his investments align with Telegraph Hill Partners' overarching mission to support companies with significant market potential and societal impact.

Before joining Telegraph Hill Partners, Deval Lashkari built a robust foundation in healthcare strategy and operations. He honed his analytical and strategic skills as a consultant at McKinsey & Company, where he advised leading pharmaceutical, medical device, and healthcare services companies on critical strategic initiatives. This experience provided him with invaluable insights into the complexities of the healthcare ecosystem, from R&D to commercialization and market access. His academic background further underscores his commitment to the field; Deval earned his Master of Business Administration (MBA) from the Wharton School at the University of Pennsylvania and holds a Bachelor of Science (BS) in Biomedical Engineering from Johns Hopkins University. This unique blend of scientific understanding, business acumen, and strategic consulting experience positions him as a highly effective and insightful investor.

At Telegraph Hill Partners, Deval Lashkari is known for his hands-on approach, working closely with portfolio companies to help them navigate challenges, scale operations, and achieve their strategic objectives. While specific public disclosures of all his notable investments are proprietary, his work at THP includes involvement with innovative companies like Element Biosciences, a developer of disruptive DNA sequencing technology, and Genapsys, focused on high-performance sequencing solutions. These examples illustrate his commitment to backing companies that bring truly novel technologies to market, addressing unmet needs in research and clinical diagnostics. Deval's leadership and strategic guidance are vital in helping these ventures translate scientific breakthroughs into commercial success and meaningful impact.

Through his dedicated work at Telegraph Hill Partners, Deval Lashkari continues to be a driving force in the evolution of healthcare and life sciences. His expertise in diagnostics, research tools, and digital health, combined with his extensive background, makes him a crucial partner for entrepreneurs aiming to innovate and grow in these dynamic sectors. He embodies THP's commitment to fostering the next generation of healthcare leaders and technologies.